LEVETRAL

Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
Adjunctive therapy:
• in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents, children from 4 years with epilepsy.
• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy

This is only the preview. Please check here for the full indication.

Anatomical Therapeutic Chemical: N
Dosage form: Film coated tablet
Packaging: 10's x 3, 10's x 6
Therapeutic area: Active pharmaceutical ingredient: